Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

UbiQ (Ubiquitin)

UbiQ (Ubiquitin)?uq=BoBgMMEs
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of ubiquitin research tools created to expedite drug discovery in the rapidly expanding ubiquitin field. The company's ubiquitin research tools include ubiquitinated peptides, ubiquitin-based reagents and high throughput specific HTS assays which use automated solid phase peptide synthesis, enabling Pharma companies and academic research labs to allocate and expedite drug discovery in the rapidly expanding ubiquitin field.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Internet Retail
Primary Office
  • Science Park 408
  • 1098 XH Amsterdam
  • Netherlands

+31 020 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore UbiQ (Ubiquitin)’s full profile, request a free trial.

UbiQ (Ubiquitin) Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

UbiQ (Ubiquitin) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ACE Venture Lab Accelerator/Incubator 000 0000 000000 0

UbiQ (Ubiquitin) Executive Team (3)

Name Title Board
Seat
Contact
Info
Farid El Oualid Ph.D Co-Founder, Chief Operating Officer & Co-CSO
Huib Ovaa Ph.D Scientific Co-Founder
Alfred Nijkerk Co-Founder & Chief Executive Officer